Patents
Patents for C07C 271 - Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups (15,621)
09/2013
09/04/2013CN103275083A Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
09/04/2013CN103274968A Method for producing amantadine compound
09/04/2013CN103274967A Tri-functional polyurethane acrylate, and preparation method and application thereof
09/03/2013CA2612292C Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use
08/2013
08/29/2013WO2013126803A1 Trialkyl cationic lipids and methods of use thereof
08/29/2013US20130225789 Polyethylene Glycol Having Hetero Multiple Functional Groups
08/28/2013CN103265523A Cardanol cyclic carbonate and its quaternary ammonium salt derivatives and preparation method thereof
08/28/2013CN103265457A (R)-4-amino phenethyl-(2-hydroxy-2-phenylethyl)-tert-butyl carbamate synthesis method
08/28/2013CN101835745B Process for production of disulfonic acid compound, asymmetric mannich catalyst, process for production of beta-aminocarbonyl derivative, and novel disulfonate salt
08/27/2013US8519174 Metal carbamates formed from diaminophenylmethane
08/22/2013US20130217764 Peripherally restricted faah inhibitors
08/22/2013US20130217706 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
08/22/2013US20130217660 Novel prolylcarboxypeptidase inhibitors
08/21/2013CN103261153A Purification of precursor compound by crystallisation
08/21/2013CN103254101A Method and equipment for preparation of methyl carbamate
08/20/2013CA2597130C Organic silver complexes, their preparation methods and their methods for forming thin layers
08/15/2013US20130211130 Process for preparing carboxamidine compounds
08/15/2013US20130211045 Macrocyclic modulators of the ghrelin receptor
08/15/2013US20130209483 Cannabidinoid derivatives
08/14/2013EP2625161A1 Method for preparing an amino acid from 2-aminobutyrolactone
08/14/2013CN103249719A Matrix metalloproteinase inhibitors
08/14/2013CN103242200A Preparation method of Nalpha-fluorenylmethoxycarbonyl-Nepsilon-acetyl-lysine
08/14/2013CN102513087B Catalyst for synthesizing phenyl carbamate from diphenyl urea, preparation method and application
08/14/2013CN102358725B Preparation method of intermediate of isoxazole compound
08/14/2013CN101932556B Diurethane compound, process for producing the same, and acrylic rubber composition containing the same
08/14/2013CN101589022B Method for producing isocyanate
08/08/2013WO2013116715A1 Methods and intermediates for preparing pharmaceutical agents
08/08/2013WO2013116174A1 Mglu 2/3 agonists
08/08/2013WO2013114379A1 Novel polymorphs of n-[2-amino-4-(4-fluorobenzylamino)-phenyl] carbamic acid ethyl ester and processes thereof
08/08/2013WO2013114315A1 Process and intermediates for the preparation of retigabine
08/08/2013US20130203846 Phenyl carbamate compounds for use in preventing or treating als
08/08/2013US20130203727 Napht-2-ylacetic acid derivatives to treat aids
08/07/2013CN103232422A A light-sensitive expansionary polymer and a preparation method and applications thereof
08/07/2013CN103232370A Preparation method of fmoc chloride glutamic acid-4-tert-butyl ester
08/07/2013CN103232369A Preparation method of fmoc chloride glutamic acid-5-tert-butyl ester
08/07/2013CN103232368A Synthesizing method of (R)-4-nitrophenethyl-(2-hydroxy-2-phenylethyl)-tert-butyl carbamate
08/07/2013CN102617403B Synthetic method of anti-senile dementia medicinal rivastigmine racemic body
08/06/2013US8501937 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support
07/2013
07/31/2013EP2619179A1 Matrix metalloproteinase inhibitors
07/31/2013CN103224458A Preparation method of HMA-HDI-HMA diacrylate macromonomer
07/31/2013CN103224457A Method and device for continuous preparation of carbamyl chloride
07/31/2013CN102030683B Sitagliptin intermediate and preparation method and application thereof
07/31/2013CN101402562B Novel benzophenone derivatives or salts thereof
07/25/2013WO2013107405A1 Therapeutically active compounds and their methods of use
07/25/2013US20130190484 In Vivo Polynucleotide Delivery Conjugates Having Enzyme Sensitive Linkages
07/25/2013US20130190371 Fungicide Active Substance Combinations
07/25/2013US20130190278 Compounds for the Treatment/Prevention of Ocular Inflammatory Diseases
07/24/2013EP2617711A1 Amino alcohol derivatives, salts thereof and immunosuppressive agents
07/24/2013CN103221382A Preparation of pet precursor
07/24/2013CN103215320A Process for preparing dipeptidyl IV inhibitors and intermediates therefor
07/24/2013CN103214399A Preparation method of N-carbobenzoxy-3-amino propionaldehyde
07/24/2013CN103214398A Method for preparing carbamate
07/24/2013CN103214383A Process for synthesis of tert-butyl glycinate and further synthesis of N-protected tert-butyl glycinate
07/24/2013CN102531966B Novel crystal form D of Retigabine and preparation method thereof
07/24/2013CN101941924B Phenol terminated diphenylmethane diisocyanate monomer adduct and preparation method thereof
07/24/2013CN101759601B Method for preparing chiral alpha-unnatural amino acid by transition metal complex
07/24/2013CN101600682B Process for making 3-substituted 2-amino-5-halobenzamides
07/24/2013CN101503373B 2-amino-1-(4-nitro phenyl)-1-ethanol metalloid protease inhibitor, and preparation and use thereof
07/23/2013US8492365 7-substituted tetracycline compounds
07/23/2013US8492311 Isoxazoline-substituted benzamide compound and pesticide
07/18/2013US20130184487 Method to produce a stable dry ionic-bonded creatine alpha ketoglutarate of high oral absorbability
07/18/2013US20130184338 Phenylpropyl carbamate derivatives for use in preventing or treating multiple sclerosis
07/18/2013US20130184279 N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
07/18/2013US20130184238 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
07/18/2013US20130184222 Therapeutically active compositions and their methods of use
07/17/2013EP2615082A2 Production of carbamates by means of base-catalyzed Lossen rearrangement
07/17/2013CN103209957A Process for preparing aminoadamantyl carbamate derivatives
07/11/2013WO2013103973A1 Carbamate compounds and of making and using same
07/11/2013US20130178643 Isocyanates and Aromatic Hydroxy Compounds
07/10/2013EP2611771A1 New compounds, pharmaceutical compositions and uses thereof
07/10/2013CN103193679A Preparation method of rivastigmine intermediate (R)-N-ethyl-N-methyl carbamic acid-3-(1-hydroxyethyl) phenyl ester
07/10/2013CN103193678A Urethane acrylate low polymer and preparation method and application thereof
07/10/2013CN103193677A Polymorphic form of methocarbamol disodium phosphate and preparation method thereof
07/10/2013CN103193676A Method for synthesizing 1-carbamate alkyl-2-naphthol by using one-pot method
07/09/2013US8481777 Metal carbamates formed from tolylenediamines
07/09/2013US8481044 Neprilysin inhibitors
07/04/2013WO2013100571A1 Phenyl carbamate compounds for use in preventing or treating als
07/04/2013WO2013100570A1 Phenyl carbamate compounds for use in preventing or treating epilesy
07/04/2013WO2013100569A1 Phenyl carbamate compounds for use in preventing or treating multiple sclerosis
07/04/2013WO2013100568A1 Phenyl carbamate compounds for use in preventing or treating stroke
07/04/2013WO2013100567A1 Phenyl carbamate compounds for use in alleviating or treating pain and neuropathic pain
07/04/2013WO2013100566A1 Phenyl alkyl carbamate derivative compound and pharmaceutical composition containing the same
07/04/2013US20130172385 Anthelmintics for preventing parasitic infections in humans and animals
07/03/2013EP2609075A1 Process for the preparation of intermediates for the manufacture of nep inhibitors
07/03/2013EP2609071A1 New process for the preparation of intermediates useful for the manufacture nep inhibitors
07/03/2013CN102584633B Lysine alpha-amino carbobenzoxy high-efficiency selective protection method and product thereof
07/03/2013CN102190602B Method of preparing benzene carbamate through continuous reactions and equipment thereof
07/02/2013CA2602003C Process for the preparation of 2-azabicyclo[3.3.0]octane-3-carboxylic acid derivatives
06/2013
06/27/2013WO2013094390A1 Photo-curable composition and patterning method
06/27/2013US20130165657 Process for preparation of optically active diamine derivative salt
06/27/2013US20130165509 Phenyl alkyl carbamate derivative compound and pharmaceutical composition containing the same
06/27/2013US20130165410 Phenyl carbamate compounds for use in preventing or treating stroke
06/27/2013US20130165409 Phenyl carbamate compounds for use in alleviating or treating pain
06/27/2013US20130165408 Phenyl carbamate compounds for use in preventing or treating epilesy
06/27/2013US20130164709 Substituted saccharide compounds and dental compositions
06/26/2013EP2606036A1 New compounds
06/26/2013CN103172541A Clean synthesis method of phenyl carbamate
06/26/2013CN103172540A Phenylglycine histone deacetylase inhibitor as well as preparation method and applications thereof
06/26/2013CN103172539A Preparation method of new diabetes drug sitagliptin intermediate aminobenzene butyric acid derivative
06/26/2013CN103172538A Method for synthesis of carbamate under mild conditions
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 ... 157